EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery

Nitish Sunil Kunte, Collin Wall, Bruno H. L. Ribeiro, Jose Noveron-Nunez, Elizabeth Schwartz, Sameer Joshi, Mohtadin Hashemi, Adriana Avila

RSC Pharmaceutics · 2026

DOI: 10.1039/d6pm00147e ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Nitish Sunil Kunte und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA vaccines require delivery vectors to protect them from degradation, to improve their cellular uptake and immunogenicity upon administration. Currently, lipid nanoparticles (LNPs) are the only FDA-approved delivery vectors for...

Zitieren

APA

Kunte, N. S., Wall, C., Ribeiro, B. H. L., Noveron-Nunez, J., Schwartz, E., Joshi, S., Hashemi, M., & Avila, A. (2026). PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00147e

Vancouver

Kunte NS, Wall C, Ribeiro BHL, Noveron-Nunez J, Schwartz E, Joshi S, et al. PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00147e

BibTeX
@article{Kunte2026,
  author = {Kunte, Nitish Sunil and Wall, Collin and Ribeiro, Bruno H. L. and Noveron-Nunez, Jose and Schwartz, Elizabeth and Joshi, Sameer and Hashemi, Mohtadin and Avila, Adriana},
  title = {PEG-Free Peptide Nanocapsules for mRNA Vaccine Delivery},
  journal = {RSC Pharmaceutics},
  year = {2026},
  doi = {10.1039/d6pm00147e}
}
Kostenlos starten →